Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) were down 1.2% during mid-day trading on Thursday . The stock traded as low as $0.40 and last traded at $0.40. Approximately 6,976,511 shares were traded during mid-day trading, a decline of 76% from the average daily volume of 28,619,661 shares. The stock had previously closed at $0.41.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the stock. Roth Capital reiterated a "neutral" rating on shares of Tilray in a research note on Monday, April 14th. Piper Sandler cut their price objective on Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a report on Wednesday, April 9th.
Check Out Our Latest Report on TLRY
Tilray Stock Performance
The business's fifty day moving average is $0.47 and its 200-day moving average is $0.85. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The company has a market cap of $408.23 million, a PE ratio of -1.35 and a beta of 1.95.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The business had revenue of $185.78 million for the quarter, compared to analysts' expectations of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. As a group, research analysts predict that Tilray Inc will post -0.2 EPS for the current fiscal year.
Institutional Trading of Tilray
Several hedge funds have recently bought and sold shares of TLRY. Dimensional Fund Advisors LP raised its stake in shares of Tilray by 54.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company's stock worth $2,890,000 after buying an additional 769,569 shares during the period. JPMorgan Chase & Co. raised its stake in Tilray by 112.7% during the 4th quarter. JPMorgan Chase & Co. now owns 919,082 shares of the company's stock worth $1,222,000 after acquiring an additional 487,051 shares during the period. Raymond James Financial Inc. bought a new stake in Tilray during the 4th quarter worth approximately $255,000. Atria Wealth Solutions Inc. lifted its holdings in Tilray by 174.7% during the fourth quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company's stock valued at $112,000 after purchasing an additional 53,751 shares in the last quarter. Finally, Tidal Investments LLC boosted its position in shares of Tilray by 9.2% in the fourth quarter. Tidal Investments LLC now owns 10,595,264 shares of the company's stock worth $14,092,000 after purchasing an additional 889,086 shares during the period. Institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
